-
New COVID 19 Treatment Options Amid Falling Reported New Cases
SHEM OIRERE
August 16, 2023
The proportion of countries reporting COVID 19 cases has been declining since mid-2022 even as testing for and reporting of new cases reduce hence impacting uptake of drugs and associated active pharmaceutical ingredients.
-
Nature Scientific Reports publishes novel AI technique that can automatically detect poor-quality medical data and improve healthcare AI and data privacy
prnasia
September 13, 2021
DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore...
-
DiaCarta Receives CE/IVD for its New COVID 19 test that Identifies Delta Plus and New Variants
prnewswire
August 13, 2021
DiaCarta Inc., today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and rest of the world.
-
Virtual Shopping Mall Opening in Central PA
prnewswire
July 16, 2021
What is, apparently, the first Virtual Mall in the United States is slated for a July 19th opening.
-
TIFAC releases report on status, issues, technology readiness and challenges in API production
expresspharma
July 16, 2020
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the strengths, market trends, and opportunities in five sectors, including healthcare.
-
It’s time to be more vigilant and quality conscious
expresspharma
June 23, 2020
Dr Ashok Omray, Advisor Pharma Operations, Ex AVP, USV and Ex-President, ICPL shares how crucial it is to ensure that quality standards are met and sustained in the pharma industry despite any challenges or crisis faced.
-
Lincoln Pharma gets approval to manufacture hydroxychloroquine
expresspharma
April 28, 2020
After necessary approval from the DGFT, the company will be able to export these products.